Masana L, Rubiés-Prat J, Nubiola A R, Masdeu S, de Sobregrau R C
Biomedicine. 1981 May;35(2):42-3.
Serum high-density lipoprotein cholesterol (HDL-C) has been determined in 85 patients with peripheral vascular disease (PVD) and in 72 healthy control subjects. HDL-C levels were significantly decreased in patients with PVD. Considering other vascular risk factors as diabetes mellitus, smoking and hypertension, there were no differences in HDL-C levels. Twenty-three patients received heparin as treatment, this subgroup showed a HDL-C levels higher than patients who were not under heparin therapy. The possible clinical implications of these facts are discussed.
已对85例周围血管疾病（PVD）患者和72名健康对照者测定了血清高密度脂蛋白胆固醇（HDL-C）。PVD患者的HDL-C水平显著降低。考虑到其他血管危险因素，如糖尿病、吸烟和高血压，HDL-C水平没有差异。23例患者接受肝素治疗，该亚组的HDL-C水平高于未接受肝素治疗的患者。讨论了这些事实可能的临床意义。
